Goldman (NYSE:GS) Keeps "Sell" Rating on Intuitive Surgical (NASDAQ:ISRG)

Even though Goldman Sachs (NSYE:GS) raised their price target and EPS estimates on Intuitive Surgical (NASDAQ:ISRG), they remain negative on the company, keeping their "Sell" rating on it.

Goldman raised full year 2011-2014 EPS estimates from $9.92/$11.66/$13.42/$15.08 to $10.79/$12.68/$14.75/$16.63.

The reasoning for Goldman is the strong results for Intuitive Surgical in the fourth quarter were driven by inventory stocking, an it appears their penetration in the U.S. market is reaching peak levels, as evidenced in the 9 percent drop in initial system placements.

Intuitive closed Monday at $327.99, gaining $1.41, or 0.43 percent. Goldman raised their price target on them from $220 to $270.